Nucleic acid amplification testing of hepatitis B virus
Nucleic acid amplification testing of hepatitis B virus
复制标题
乙型肝炎病毒核酸扩增检测
DOI:
10.1016/s0140-6736(05)74655-9
复制
发表时间:
2000
期刊:
影响因子:
--
通讯作者:
K. Nishioka
中科院分区:
文献类型:
--
作者:
K. Otake;K. Nishioka
Sir—Arif Khwaja and colleagues (Feb 26, p 741) 1 postulate that prenylation inhibitors could be used to treat proliferative renal diseases. These investigators also discuss pravastatin’s ability to decrease acute and chronic rejection in organ transplantation and suggest that these effects “are due to inhibition of Ras and Rho prenylation with subsequent inhibition of the proliferation of vascular smooth muscle, which is an essential histological feature of chronic rejection”. Indeed, the ability of status to inhibit vascular smooth muscle proliferation (at high concentrations) may contribute to its chronic-rejection prevention properties. Also, statins and other prenylation inhibitors may inhibit acute and chronic rejection by suppressing T-cell activation and function.We have shown that pravastatin inhibits T-cell proliferation in vitro and that this effect is abrogated by addition of farensyl pyrophosphate but not cholesterol. 2 This finding confirms our hypothesis that prenylation inhibitors suppress T-cell activation and function by interfering with protein isoprenylation. We have also shown that perillyl alcohol, a naturally occurring prenylation inhibitor, inhibits acute rejection, Th1 cytokine expression, and alloantibody production in a rat cardiac transplant model. 3 Perillyl alcohol also interfered with T-cell activation, motility, and normal polarity. 4 Furthermore, we showed that perillyl alcohol preferentially induced apoptosis in activated T cells. Our findings, along with the well-documented roles of Ras GTPases in T-cell activation and function confirm our hypothesis that isoprenylation inhibitors (the Ras inhibitors), are effective antirejection agents.